Mechanisms of Homoarginine: Looking Beyond Clinical Outcomes
Acta Physiologica · 2025-02 · 241 (2)
DOI: 10.1111/apha.14273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Physiologica, online erschienen am 16.01.2025. Verfasst von Ashley Zubkowski und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Homoarginine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lister Institute of Preventive Medicine, Genome Alberta, Medical Research Council.
Abstract (Originalsprache)
Purpose
Homoarginine (hArg) is an arginine metabolite that has been known for years, but its physiological role in the body remains poorly understood. For instance, it is well known that high hArg concentrations in the blood are protective against several disease states, yet the mechanisms behind these health benefits are unclear. This review compiles what is known about hArg, namely its synthetic pathways, its role in different diseases and conditions, and its proposed mechanisms of action in humans and experimental animals.
Findings
Previous work has identified multiple pathways that control hArg synthesis and degradation in the body. Furthermore, endogenous hArg can modulate the cardiovascular system, with decreased hArg being associated with cardiovascular complications and increased mortality. Studies also suggest that hArg could serve as a diagnostic biomarker for a variety of immune, pancreatic, renal, and hepatic dysfunctions. Finally, in women, hArg concentrations rapidly increase throughout pregnancy and there are suggestions that alterations in hArg could indicate pregnancy complications like pre‐eclampsia. Summary Homoarginine is an under‐appreciated amino acid with potential wide‐ranging roles in systemic health, pregnancy, and pathophysiology. Although recent research has focused on its health or disease associations, there is a need for more investigations into understanding the mechanistic pathways by which hArg may operate. This could be aided using metabolomics, which provides a comprehensive approach to correlating multiple metabolites and metabolic pathways with physiological effects. Increasing our knowledge of hArg's roles in the body could pave the way for its routine use as both a diagnostic and therapeutic molecule.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada.
- Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
- Department of Computer Sciences, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Ashley Zubkowski, Amanda N Sferruzzi-Perri, David S Wishart
Förderung
- Lister Institute of Preventive Medicine
- Genome Alberta
- Medical Research Council
- Canada Foundation for Innovation
Zitieren
APA
Zubkowski, A., Sferruzzi-Perri, A. N., & Wishart, D. S. (2025). Mechanisms of Homoarginine: Looking Beyond Clinical Outcomes. Acta Physiologica, 241(2). https://doi.org/10.1111/apha.14273
Vancouver
Zubkowski A, Sferruzzi-Perri AN, Wishart DS. Mechanisms of Homoarginine: Looking Beyond Clinical Outcomes. Acta Physiologica. 2025;241(2). doi:10.1111/apha.14273
BibTeX
@article{Zubkowski2025,
author = {Zubkowski, Ashley and Sferruzzi-Perri, Amanda N and Wishart, David S},
title = {Mechanisms of Homoarginine: Looking Beyond Clinical Outcomes},
journal = {Acta Physiologica},
year = {2025},
volume = {241},
number = {2},
doi = {10.1111/apha.14273}
}
EUVIMED